Volume 64, Issue 3, Pages (September 2003)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Michael Allon, Michelle L. Robbin Kidney International

Endovascular Salvage of Nonmaturing Autogenous Hemodialysis Fistulas: Comparison with Endovascular Therapy of Failing Mature Fistulas Hannu I. Manninen,

Volume 69, Issue 1, Pages (January 2006)

Volume 61, Issue 1, Pages (January 2002)

Associations Between Low Serum Testosterone and All-Cause Mortality and Infection- Related Hospitalization in Male Hemodialysis Patients: A Prospective.

Volume 69, Issue 5, Pages (March 2006)

Anemia management in chronic kidney disease

Volume 83, Issue 3, Pages (March 2013)

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Volume 68, Issue 2, Pages (August 2005)

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

Vascular access in hemodialysis patients older than 80 years

G protein β3 subunit C825T polymorphism in primary IgA nephropathy

Comparative outcomes of primary autogenous fistulas in elderly, multiethnic Asian hemodialysis patients Claude J. Renaud, MRCP (UK), FAMS, Jackie Ho.

Steven J. Chadban, Natalie D. Staplin Kidney International

Volume 66, Issue 3, Pages (September 2004)

William C. Jennings, MD, Matthew J. Sideman, MD, Kevin E

Volume 73, Issue 5, Pages (March 2008)

Comorbidity and confounding in end-stage renal disease

Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.

Volume 70, Issue 11, Pages (December 2006)

Renal risk scores: Progress and prospects

Volume 65, Issue 2, Pages (February 2004)

Volume 68, Issue 1, Pages (July 2005)

The role of protein kinase C activation in diabetic nephropathy

Study of Heart and Renal Protection (SHARP)

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

Saulo Klahr, Jeremiah J. Morrissey Kidney International

Volume 70, Issue 12, Pages (December 2006)

Anemia as a risk factor for cardiovascular disease

Primary and staged transposition arteriovenous fistulas

Volume 76, Issue 6, Pages (September 2009)

Andre Biuckians, MD, MPH, Eric C. Scott, MD, George H

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 62, Issue 5, Pages (November 2002)

Mingzheng Aaron Goh, MBChB, AFHEA, MRCS, Jason M

Volume 61, Issue 2, Pages (February 2002)

Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease Yoshiki Nishizawa,

Racial disparities in access to transplantation: a tough nut to crack

Volume 60, Issue 6, Pages (December 2001)

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 67, Issue 5, Pages (May 2005)

Homocysteine, renal function, and risk of cardiovascular disease

Volume 78, Issue 5, Pages (September 2010)

Volume 68, Issue 1, Pages (July 2005)

Infrainguinal arterial reconstructions in patients with aortoiliac occlusive disease: The influence of iliac stenting Carlos H. Timaran, MD, Scott L.

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Volume 65, Issue 5, Pages (May 2004)

Volume 61, Issue 5, Pages (May 2002)

Volume 66, Issue 1, Pages (July 2004)

Treatment of the primary hyperoxalurias: A new chapter

Volume 62, Issue 3, Pages (September 2002)

Volume 64, Issue 4, Pages (October 2003)

Volume 62, Issue 5, Pages (November 2002)

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

M. Chris Pastor, MD, MSc, David Kopriva, MDCM, FRCS(C)

Volume 55, Issue 2, Pages (February 1999)

Volume 70, Issue 5, Pages (September 2006)

Creating functional autogenous vascular access in older patients

Antioxidant therapy in hemodialysis patients: a systematic review

Ivan D. Maya, Michael Allon Kidney International

Volume 67, Issue 5, Pages (May 2005)

Graft flow as a predictor of thrombosis in hemodialysis grafts

Volume 87, Issue 6, Pages (June 2015)

Lipoprotein abnormalities in diabetic nephropathy

Prediction in idiopathic membranous nephropathy

Volume 60, Issue 2, Pages (August 2001)

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 64, Issue 3, Pages 1101-1107 (September 2003) Transforming growth factor β1 genotype polymorphisms determine AV fistula patency in hemodialysis patients Gunnar H. Heine, Christof Ulrich, Urban Sester, Martina Sester, Hans Köhler, Matthias Girndt Kidney International Volume 64, Issue 3, Pages 1101-1107 (September 2003) DOI: 10.1046/j.1523-1755.2003.00176.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan-Meier analysis of arteriovenous (AV) fistula patency stratified by transforming growth factor β1 (TGF-β1) producer type. By log-rank test, AV fistula patency was significantly better for TGF-β1 intermediate producers (solid line) compared to TGF-β1 high producers (dotted line); P = 0.0046. TGF-β1 low producers were too low in number to allow a valid statistical comparison to intermediate and high producers. Kidney International 2003 64, 1101-1107DOI: (10.1046/j.1523-1755.2003.00176.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan-Meier analysis of arteriovenous (AV) fistula patency stratified by age. By log-rank test, AV fistula patency did not differ significantly between patients who were younger than 50years of age (dotted line), 50 to 64years of age (dashed line), and 65years of age and older (solid line), respectively. P = 0.10. Kidney International 2003 64, 1101-1107DOI: (10.1046/j.1523-1755.2003.00176.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Kaplan-Meier analysis of arteriovenous (AV) fistula patency stratified by primary renal disease. By log-rank test, AV fistula patency did not differ significantly between patients with diabetic nephropathy (dotted line) and patients with any other primary renal disease (solid line). P = 0.30. Kidney International 2003 64, 1101-1107DOI: (10.1046/j.1523-1755.2003.00176.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Kaplan-Meier analysis of arteriovenous (AV) fistula patency stratified by comorbidity. By log-rank test, AV fistula patency did not differ significantly between patients with cardiovascular disease (dotted line) and patients without cardiovascular disease (solid line). P = 1.00. Kidney International 2003 64, 1101-1107DOI: (10.1046/j.1523-1755.2003.00176.x) Copyright © 2003 International Society of Nephrology Terms and Conditions